Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Lifeway Foods
LWAY
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By product
See full
Net Sales
100%
0.0%
Drinkable Kefirotherthan Pro Bugs
87%
+4.8%
Cheese
7%
-12.5%
Cream And Other
3%
-40.0%
Drinkable Yogurt
1%
0.0%
Other Dairy
1%
0.0%
Other financials
Income statement
See full
Revenue
$63.0M
+36.7%
Gross profit
$17.4M
+57.2%
Operating income
$6.3M
+302%
Net income
$4.7M
+32.0%
EPS (diluted)
$0.30
+30.4%
Balance sheet
See full
Cash & equivalents
$5.6M
-71.2%
Total debt
$627.0K
+475%
Total equity
$90.3M
+21.8%
Total assets
$120.5M
+28.7%
Cash flow
See full
Operating cash flow
$4.4M
+3,019%
CapEx
$11.0M
+398%
Free cash flow
-$6.7M
-181%
Valuation
See full
Market cap
$463.5M
+24.3%
Enterprise value
$458.52M
+29.7%
P/E
30.9×
-5.3×
P/S
2×
0.0×
Profitability
See full
Gross margin
28.1%
+2.6pp
Operating margin
9.1%
+2.8pp
Net margin
6.5%
+1.1pp
FCF margin
-9.7%
—
Returns & leverage
See full
Return on equity
18.2%
+3.3pp
Debt / equity
0×
0.0×
Current ratio
2.1×
-0.8×